AVALUS AORTIC TISSUE VALVE
Report
- Report Number
- 2025587-2020-01992
- Event Type
- Injury
- Date Received
- June 23, 2020
- Date of Event
- May 22, 2020
- Report Date
- June 23, 2020
- Manufacturer
- MEDTRONIC HEART VALVES DIVISION
- Product Code
- LWR
- UDI-DI
- 00643169983199
- PMA / PMN Number
- P170006
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MN, US
- Reporter Occupation
- PHYSICIAN
Narratives
OTHER RELEVANT DEVICE(S) ARE: PRODUCT ID: 620BG29, SERIAL/LOT #: (B)(4), PMA #: K032810, UBD: 05-JUL-2022, UDI#: (B)(4). PRODUCT ID: 900SFC32, SERIAL/LOT #: (B)(4), PMA #: K093903, UBD: 11-JAN-2024, UDI#: (B)(4). PRODUCT ANALYSIS: THE DEVICES REMAINS IMPLANTED; THEREFORE, NO PRODUCT ANALYSIS CAN BE PERFORMED. CONCLUSION: WITHOUT THE RETURN OF THE PRODUCTS, NO DEFINITIVE CONCLUSION CAN BE MADE REGARDING THE CLINICAL OBSERVATION. CONDUCTION DISTURBANCES ARE KNOWN POTENTIAL ADVERSE EFFECTS ASSOCIATED WITH ANY CARDIAC OR THORACIC PROCEDURE AND CAN BE RESOLVED WITH MEDICAL TREATMENT OR THE IMPLANT OF A PERMANENT PACEMAKER. A CONDUCTION DISTURBANCE DOES NOT INDICATE A DEVICE MALFUNCTION OR POTENTIAL MANUFACTURING ISSUE. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
MEDTRONIC RECEIVED INFORMATION THAT 5 DAYS POST IMPLANT OF THIS 23MM BIOPROSTHETIC AORTIC VALVE, 12 DAYS POST IMPLANT OF THIS 29 MM MITRAL ANNULOPLASTY BAND, AND 12 DAYS POST IMPLANT OF THIS 32MM TRICUSPID ANNULOPLASTY RING, A PERMANENT PACEMAKER WAS IMPLANTED IN THE PATIENT. THE REASON FOR THE PERMANENT PACEMAKER IMPLANT WAS REPORTED AS COMPLETE HEART BLOCK. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 647494 | AVALUS AORTIC TISSUE VALVE | HEART-VALVE, NON-ALLOGRAFT TISSUE | LWR | MEDTRONIC HEART VALVES DIVISION | 40023 | 00643169983199 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 63 YR | Required Intervention |